Monsanto Pleased with Shareholders’ Approval of Bayer Merger




Innovation is crucial to the progress of companies like Monsanto (MON), Syngenta (SYT), Dow Chemicals (DOW), and FMC Corporation (FMC), and it’s often the one to innovate the fastest that dominates the market. Monsanto’s merger with Bayer could help both companies do just that.

Article continues below advertisement

Shareowners approve

During a recent press release, Monsanto’s management stated: “We’ve been very pleased with the strong support—especially from shareowners and growers—for the agreement to combine with Bayer.”

The management also noted: “We expect the combination with Bayer to amplify the rate of innovation faster than either company could achieve alone, which will be critical in helping to increase grower productivity to meet projected demand in the decades ahead.”

Regulatory scrutiny

The transaction has nearly one year until completion and is expected to close by the second quarter of 2018. During this period, the company will be scrutinized by regulatory agencies, particularly the anti-trust committees of the respective countries. Other announced mergers include PotashCorp (POT) and Agrium (AGU) and Syngenta (SYT) and Chem China, and both pairs will be facing similar scrutiny from anti-trust committees.

We’ll cover more about Monsanto’s earnings following the company’s earnings call.

In the meantime, keep checking in with Market Realist’s Agricultural Fertilizer (MXI) page for ongoing updates.


More From Market Realist